Skip to Main Content
Skip Nav Destination
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Drug hypersensitivity reactions (DHRs) are the adverse effectsof drugs, taken at a dose which is tolerated by normalsubjects, which clinically resemble allergy. There are fewtrue epidemiological data on DHRs. The available informationrequires a cautious interpretation because the pathogenicmechanism has not been demonstrated by diagnostictests. Both under- and over-diagnosis must be taken intoaccount. DHRs may represent up to one third of adversedrug reactions, be life-threatening, require or prolong hospitalization,and entail changes in drug prescription. Theyconcern more than 7% of the general population, andtherefore are an important public health problem. A few riskfactors have been pinpointed. Future progress in genetics,as well as well-designed epidemiological studies on hypersensitivitydrug reactions, will be helpful in identifying patientsat risk of developing such reactions, in particular severeones, and in implementing early preventive measures.This review describes current data on the incidence, prevalence,mortality, and risk factors of these reactions.

Send Email

Recipient(s) will receive an email with a link to 'Drug Hypersensitivity > 2 - 17: Epidemiology and Causes of Drug Hypersensitivity' and will not need an account to access the content.

Subject: Drug Hypersensitivity > 2 - 17: Epidemiology and Causes of Drug Hypersensitivity

(Optional message may have a maximum of 1000 characters.)

×

Data & Figures

Contents

References

Close Modal

or Create an Account

Close Modal
Close Modal